No Data
No Data
Canature health technology (300272.SZ): For many years, the company's export revenue has accounted for more than 60%.
Canature Health Technology (300272.SZ) stated on its investor platform that for many years, the company's export revenue accounted for more than 60%. Settlement currencies are in US dollars and euros, and mainly deposited domestically. Considering recent exchange rates and differences in deposit and loan interest rates, the company chose to hold foreign currencies, as well as borrowing in renminbi for daily operations, and timely foreign exchange settlement based on market conditions and liquidity. Domestic and foreign currency deposits are demand deposits, with unrestricted liquidity and no outstanding approvals pending.
Canature Health Technology (300272.SZ): Overseas orders are full, Europe and Asia orders are completed locally in Shanghai or Jiangsu.
On July 16, 2024, Canature Health Technology (300272.SZ) conducted an investor survey regarding "Overseas situation and production line situation?". The company replied that overseas orders are full, and European and Asian orders are completed locally in Shanghai or Jiangsu with a stable delivery period. Canature North America has an assembly line for core components from domestic warehouses to the assembly line.
Canature Health Technology (300272.SZ): The RO reverse osmosis water purifier uses RO reverse osmosis technology.
On July 17th, Gelonhui reported that an investor had asked Canature Health Technology (300272.SZ) on the investor interaction platform, "Can the company's products filter bromate?" The company replied that RO reverse osmosis is an efficient membrane separation technology that can remove various ions and organic matter in water, including bromate, to achieve safe levels. The company's RO reverse osmosis water purifier uses RO reverse osmosis technology.
Canature Health Technology (300272.SZ) has repurchased 1.2227% of its shares.
Canature Health Technology (300272.SZ) announced on July 2nd that the company repurchased 7.0574 million shares of its own stock through a repurchase dedicated securities account using centralized bidding trading method, which accounted for 1.2227% of the company's total equity. The highest fill price was 4.446 yuan/share, and the lowest fill price was 3.84 yuan/share. The total amount paid was 29,056,700 yuan (excluding transaction fees).
Canature Health Technology (300272.SZ) has cumulatively spent 29.0567 million yuan to repurchase 7.0574 million shares.
Canature Health Technology (300272.SZ) announced that the company repurchased 7.0574 million shares of the company through a dedicated securities account using centralized bidding trading, accounting for 1.2227% of the total equity. The highest fill price was 4.446 yuan/share, the lowest fill price was 3.84 yuan/share, and the total amount paid was 29,056,700 yuan (excluding transaction fees).
Kaineng Health (300272.SZ) plans to pay 1 yuan for every 10 shares in 2023, excluding interest on May 28
Zhitong Finance App News, Kaineng Health (300272.SZ) announced that in 2023, the company plans to distribute a cash dividend of RMB 1 (tax included) to all shareholders for every 10 shares. The share registration date is May 27, 2024; the exclusion date is May 28, 2024.
No Data